Oral Contraceptives To Lose Category X Pregnancy Labeling Under Guidance
Executive Summary
FDA is developing a draft guidance to remove pregnancy Category X labeling from oral contraceptives
You may also be interested in...
Barr Plan B OTC Should Not Be Kept Behind Pharmacy Counter, Cmte. Says
Barr's Plan B emergency contraceptive should be available without a prescription and not restricted to "behind-the-counter" distribution at pharmacies, FDA's Reproductive Health and Nonprescription Drugs Advisory Committees said Dec. 16
Pregnancy Labeling Updates Could Include Published Data, Not Just Trials
FDA plans to rely on data other than randomized controlled studies when it updates drug labels under the forthcoming pregnancy labeling rule.
Part D Discount Liability Coming Into Focus: CMS Releases Drug Cost Data
Newly released Medicare Part D data sheds light on the sales hit that branded pharmaceutical manufacturers will face when the coverage gap discount program gets under way in 2011